Rowan E Miller - Department of Medical Oncology, Barts Health NHS Trust

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 139 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Pembrolizumab in Patients with Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial

Rebecca Kristeleit,Michael-John Devlin,Andrew Clamp,Charlie Gourley,Rene Roux,Marcia Hall,Rachel Nirsimloo,Valentinos Kounnis, Lesley Sage, Priya Narayanan, C. Simon Herrington, Rupali Arora,Laura Farrelly, Laura Hughes,Nicholas Counsell,Rowan E. Miller

JAMA ONCOLOGY (2025)

Cited0Views0WOSBibtex

Corrigendum to ‘A Phase Ib, Open-Label Trial of MOv18 IgE in Patients with Advanced Ovarian Cancer’ [international Journal of Gynecological Cancer Volume 35, Issue 2 Supplement 1 (2025) #809]

Rebecca Kristeleit,Bristi Basu,Rowan Miller,Jose Iglesias, Andrew Calam, Rachel Nirsimloo, Clare Green,Axel Walther, Christopher Twelves,James Spicer

International Journal of Gynecological Cancerno. 5 (2025)

Cited0Views0Bibtex

Real World Outcomes in Patients with Recurrent, Advanced or Metastatic Endometrial Cancer Treated with Lenvatinib Plus Pembrolizumab

A. Pawsey, P. Mahalingam, N. Senthivel, A. Ramessur, E. Turnbull, S. Usman, R. Browne, A. Patel, A. Stewart,L. Tookman,N. Counsell,R. Miller,S. Nicum,G. Eminowicz

CLINICAL ONCOLOGY（2025）

Cited0Views0WOSBibtex

The Impact of Inter-Cycle Treatment Delays on Overall Survival in Patients with Advanced-Stage Ovarian Cancer

Luke Steventon,Kenneth K. C. Man,Shibani Nicum,Rowan E. Miller,Shira Peleg Hasson, Samixa Shah, Michael Baser,Emma Kipps,Martin D. Forster, Ofran Almossawi,Pinkie Chambers

ONCOLOGIST（2024）

Cited0Views0WOSBibtex

The Impact of Inter-Cycle Treatment Delays on 5-Year All-Cause Mortality in Early-Stage Breast Cancer: a Retrospective Cohort Study

Luke Steventon,Emma Kipps,Kenneth K. C. Man,Rebecca Roylance,Martin D. Forster,Ian C. K. Wong, Michael Baser,Rowan E. Miller,Shibani Nicum, Samixa Shah, Ofran Almossawi,Pinkie Chambers

EUROPEAN JOURNAL OF CANCER（2024）

Cited1Views0WOSBibtex

715 an 8 Year Retrospective Review of Gynae-Oncology Patients Treated at a Central London Early Phase Trials Unit

Uma Mukherjee, Fatjon Dekaj, Angel Luis Orosco-Ttamina,Michael Flynn,Martin Forster,Rowan Miller

International Journal of Gynecological Cancer (2024): A266

Cited0Views0Bibtex

TP010/#1537 Efficacy and Safety of Luveltamab Tazevibulin in Patients with Recurrent Platinum-Resistant Ovarian Cancer: the Reframe-01 (GOG-3086, ENGOT-79ov, and APGOT-OV9) Phase 2/3 Study

Ana Oaknin,Domenica Lorusso,Klaus Pietzner,Jung-Yun Lee,David Cibula,Yeh Chen Lee,Russell Schilder,Annika Auranen, Bo Gao, David Tan,Amit Oza,Rowan Miller,Vanda Salutari,Giulia Tasca, David O’Malley,Bradley Monk,Bhavana Pothuri, Lin Lu, Craig Berman, Anne Borgman

International Journal of Gynecological Cancer（2024）

Cited0Views0Bibtex

Monitoring Clone Dynamics and Reversibility in Clonal Haematopoiesis and Myelodysplastic Neoplasm Associated with PARP Inhibitor Therapy—a Role for Early Monitoring and Intervention

Ellen Nuttall Musson,Rowan E. Miller,Marc R. Mansour,Michelle Lockley,Jonathan A. Ledermann,Elspeth M. Payne

Leukemiano. 1 (2024): 215-218

Cited1Views0WOSNATUREBibtex

Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London

Karim H. El-Shakankery,Joanna Kefas,Kieran Palmer,Andrew Houston,Uma Mukherjee, Kangbo Gao, Weiteen Tan,Shanthini M. Crusz,Michael J. Flynn,Jonathan A. Ledermann,Michelle Lockley,Mary McCormack,Nicola MacDonald,Shibani Nicum,Michael John Devlin,Rowan E. Miller

CANCERS（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn